Stock Evaluator: Codexis, Inc. (CDXS)

Codexis, Inc. CDXS

$1.05 -0.10 -8.70%
November 19, 2026 4:00:00 PM EST November 10, 2021 Volume: 913,303
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Life Sciences Tools & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Commentary & Analysis


Financial Summary

Share Statistics CDXS Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $115.1 $3,419.7 24%
Shares Out (Mil) 107.3 105.4 63%
Institutional Ownership 90.6% 89.4% 58%
Float (Mil) 94.7 77.0 59%
Beta 2.39 1.16 95%
Avg Daily Volume (000s) 1,158 1,070 72%
Price Change
(52-week)
(36.0%) 82.9% 28%
Growth CDXS Industry
Median
Percentile
(All Stocks)
Sales (5yr) 0.4% 7.5% 19%
Net Income (5yr) (12.9%) (12.1%) 27%
EPS (5yr) (4.6%) 2.1% 26
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (17.9%) (14.9%) 39%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 2 3 3
Current EPS ($0.140) ($0.410) ($0.340)
Month Ago EPS ($0.100) ($0.425) ($0.320)
# Rev Up 1 0 0
# Rev Down 0 1 1
Three Months Ago EPS ($0.110) ($0.420) ($0.320)
Year/Year Chg 84.2% (18.8%) (51.5%)
Financials CDXS Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $88 $811 25%
Net Income (TTM) (Mil) ($19) ($19) 24%
EPS (TTM) ($0.203) ($0.300) 32%
Operating Cash Flow (TTM) (Mil) ($11) $52 20%
Net Cash Flow (TTM) (Mil) $4 $3 53%
Long-Term Debt (Q1) (Mil) $58 $252 40%
Enterprise Value (Q1) (Mil) $127 $3,486 24%
Valuation CDXS Industry
Median
Percentile
(All Stocks)
P/B 2.23 3.21 61%
P/E na 34.9 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 6.5 na
Ratios CDXS Industry
Median
Percentile
(All Stocks)
Gross Margin 33.1% 47.8% 39%
Net Margin (21.8%) (3.0%) 16%
ROA (14.3%) (5.4%) 22%
ROE (42.9%) (5.2%) 17%
Liabilities to Assets 64.5% 41.5% 60%
F-Score 4 5 34%

Codexis, Inc. did not pass any screens on 11/19/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors